Cision Wire http://news.cision.com/ Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations. Wed, 22 May 2013 12:29:59 GMT Cision Wire 120 32 http://news.cision.com/ http://news.cision.com/ui/images/CisionLogoSmall.gif VISCOGEL INITIATES PHASE I/II CLINICAL TRIAL FOR ITS NOVEL VACCINE ADJUVANT http://news.cision.com/viscogel-ab/r/viscogel-initiates-phase-i-ii-clinical-trial-for-its-novel-vaccine-adjuvant,c9249778 cision482981

Viscogel AB today announced that dosing began in the Phase I/II clinical trial with ViscoGel®, a novel vaccine adjuvant based on the company's proprietary chitosan technology. ViscoGel® has been shown to be safe and effective in pre-clinical studies.

]]> Mon, 23 Apr 2012 09:42:37 GMT VISCOGEL AB REPORTS POSITIVE RESULTS FROM SAFETY STUDIES http://news.cision.com/viscogel-ab/r/viscogel-ab-reports-positive-results-from-safety-studies,c9225058 cision457224

Viscogel AB today announced a successful completion of the toxicology studies that were carried out within the ViVac-project. The results showed that ViscoGel® was well tolerated even at higher doses and no unexpected effects were observed.

]]> Mon, 27 Feb 2012 15:26:44 GMT Results on ViscoGel® adjuvant published in Vaccine http://news.cision.com/viscogel-ab/r/results-on-viscogel--adjuvant-published-in-vaccine,c9201025 cision431687

Preclinical results describing the efficacy of ViscoGel® - a novel vaccine adjuvant - were recently published in the peer-reviewed journal Vaccine.  The results support Proof of Concept for ViscoGel® as an effective vaccine adjuvant.

]]> Mon, 19 Dec 2011 09:46:14 GMT